← Home · All topics

Catalio Capital Management

2 GoKawiil briefs on this topic

Enveda raises $311M Series E at $2B valuation for AI-driven natural drug discovery

Enveda, a biotech startup using AI to identify drugs from plants and microbes, closed a $311 million Series E funding round at a $2 billion valuation. Catalio Capital Management led the round, with Iconiq and other investors participating. The valuation doubles what the company achieved a year earlier.

techcrunch.com · 2026-09-23

Evvy secures $40M Series B to expand vaginal microbiome testing and research

Evvy, a women's health startup, has closed a $40 million Series B funding round led by Catalio Capital Management. The company operates an at-home vaginal microbiome test that uses mNGS sequencing, serving over 100,000 patients and 3,000 practitioners across the US, and has produced 15 peer-reviewed publications from its data.

techcrunch.com · 2026-09-15